Medtech imaging company appoints Dr. Michael Lesh to its board

Elucid, a medtech imaging company using artificial intelligence to diagnose cardiovascular disease, has appointed Michael Lesh, MD, to its board.

Advertisement

Dr. Lesh is currently the CEO and founder of the data science and data privacy company Syntegra. Additionally, he serves as the executive chair of Cordance Medical, a company that uses transcranial-focused ultrasounds to treat cancer, Alzheimer’s and other brain diseases, according to a Nov. 3 Elucid news release.

“The Elucid technology is poised to become the standard of care for non-invasive diagnosis of cardiovascular disease, and I look forward to working with the company to make this a reality,” Dr. Lesh said. 

Advertisement

Next Up in Leadership

  • Leadership transitions across hospitals and physician organizations remain steady as systems look to maintain stability, advance strategic partnerships and guide…

  • Dallas-based Symmetry Anesthesia has named Aaron Stewart chief financial officer and Jennifer Grover chief operating officer. The physician-led organization tapped…

Advertisement

Comments are closed.